Private Equity
Microsoft Corp said June 4 that it agreed to buy GitHub for $7.5 billion in stock. The deal is expected to close by the end of the calendar year. GitHub, of San Francisco, is a software development platform where more than more than 28 million developers learn, share and collaborate. GitHub has raised $350 million in funding, crunchbase said. Investors include Sequoia Capital, Andreessen Horowitz and Thrive Capital.
4 min read · 04 June 2018
Myriad Genetics has agreed to acquire South San Francisco-based Counsyl, a provider of DNA screening, for $375 million. Lazard is providing financial advice to Myriad Genetics on the deal with Mintz Levin Cohn Ferris Glovsky and Popeo PC acting as legal counsel. And, Piper Jaffray is providing financial advice to Counsyl while Cooley LLP is serving as legal counsel. Counsyl's backers include Goldman Sachs, Founders Fund, Pilot Growth Equity and Felicis Ventures.
6 min read · 29 May 2018
PepsiCo Inc (Nasdaq: PEP) has agreed to acquire Bare Foods Co, which does business as Bare Snacks, a U.S. maker of baked fruit and vegetable snacks. No financial terms were disclosed. Founded in 2001, San Francisco-based Bare Snacks offers a range of real fruit baked snacks, such as crunchy apple chips, coconut chips and banana chips. Pepsi said the deal will expand nutritional options in its snacking portfolio. Bare Snacks is backed by Canadian venture capital firm Avrio Capital and U.S. firms NGEN Partners and Silas Capital, all of which invested in the company's US$$9.25 million financing in 2013.
4 min read · 25 May 2018
Kaltura, a video tech provider, has acquired Boulder, Colorado-based Rapt Media, an interactive personalized video startup. No financial terms were disclosed. Kaltura’s backers include SAP Ventures, Nokia Growth Partners, Intel Capital, Nexus Venture Partners and Commonfund Capital.
4 min read · 25 May 2018
Health insurance provider Anthem Inc has agreed to acquire Aspire Health, a non-hospice palliative care provider. No financial terms were disclosed. The deal is expected to close in the third quarter of this year. Aspire's investors include Oak HC/FT, GV, BlueCross BlueShield Venture Partners and Sandbox Industries.
3 min read · 23 May 2018
Canopy Growth Corp (TSX: WEED) has conditionally agreed to acquire the 33 percent stake of cannabis production brand BC Tweed Joint Venture Inc not currently owned by the company. With the deal's close, Canopy will issue up to $374 million worth of shares to the minority shareholders of BC Tweed. BC Tweed was launched in 2017 in partnership with Canopy and others to develop up to 3 million square feet of greenhouse growing capacity in British Columbia. The business is a spin out of SunSelect Produce Inc, a Delta, British Columbia-based vegetable producer backed by Avrio Capital and InvestEco Capital, both Canadian food and agriculture technology investors.
4 min read · 18 May 2018
EAT Club has acquired San Francisco Bay Area-based Farm Hill's personal meal business. No financial terms were disclosed. EAT Club's backers include August Capital, Trinity Ventures, First Round Capital and Sodexo.
4 min read · 18 May 2018
Dialpad has acquired TalkIQ, a provider of real-time speech recognition and natural language processing technologies. No financial terms were disclosed. Dialpad's backers include Amasia, Andreessen Horowitz, Felicis Ventures, GV, Salesforce Ventures, Scale Venture Partners, Section 32, Softbank and Work-Bench.
4 min read · 16 May 2018
HumanaCare has acquired TranQool, a Toronto-based online platform for connecting users with licensed therapists. No financial terms were disclosed for the deal, which closed on May 8. HumanaCare, a Toronto-based employee and member health services provider, said the deal will help expand access to its programs. TranQool was founded in 2015 by Chakameh Shafii, Babak Shahabi and Saeed Zeinali. In 2016, the company raised seed funding from Imagination Catalyst Fund, a university incubator-affiliated fund supported by Relay Ventures.
2 min read · 14 May 2018
Eli Lilly and Co (NYSE: LLY) has agreed to acquire AurKa Pharma Inc, a Montréal-based developer of a cancer treatment for solid tumours originally discovered by Lilly. Lilly will acquire all shares of AurKa for an upfront payment of about $141 million (US$110 million). The company's shareholders could also receive up to about $594 million (US$465 million) in regulatory and sales milestones should AurKa's compound, AK-01, be approved in the United States and other markets. AurKa was founded and financed in 2016 by TVM Capital Life Science. Lilly, a U.S. pharmaceutical business, said the acquisition will expand its oncology pipeline.
4 min read · 14 May 2018
